Robert A. Newman
Impact in
- Molecular Medicine top 0.02%
- Curcumin's Biomedical Applications
- Biochemistry top 0.2%
- Phytochemicals and Antioxidant Activities
Papers in
-
- Cancer therapeutics and mechanisms 27
- Retinoids in leukemia and cellular processes 12
- Oncology 71
- Cancer Treatment and Pharmacology 23
- Co-authors
- Bharat B. Aggarwal (10 shared papers)Ajaikumar B. Kunnumakkara (3 shared papers)Preetha Anand (1 shared paper)Ephraim Philip Lansky (5 shared papers)Peiying Yang (60 shared papers)Keith I. Block (5 shared papers)Alison D. Pawlus (3 shared papers)Razelle Kurzrock (7 shared papers)
- Journals
- Cancer Chemotherapy and Pharmacology (12 papers)Journal of Clinical Oncology (12 papers)Investigational New Drugs (10 papers)Cancer Research (7 papers)Clinical Cancer Research (7 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Robert A. Newman
299 papers receiving 17.6k citations
Robert A. Newman's Hit Papers
Peers
Comparison fields: 5 of 173
- Molecular Medicine 4.3k
- Biochemistry 956
- Pharmacology 2.6k
- Pharmaceutical Science 836
- Toxicology 467
Countries citing papers authored by Robert A. Newman
This map shows the geographic impact of Robert A. Newman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert A. Newman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert A. Newman more than expected).
Fields of papers citing papers by Robert A. Newman
This network shows the impact of papers produced by Robert A. Newman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert A. Newman. The network helps show where Robert A. Newman may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert A. Newman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 302 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bioavailability of Curcumin: Problems and Promises Hit paper breakdown → | 2007 | 4433 |
| 2 | Phase II Trial of Curcumin in Patients with Advanced Pancreatic Cancer Hit paper breakdown → | 2008 | 1064 |
| 3 | Punica granatum (pomegranate) and its potential for prevention and treatment of inflammation and cancer Hit paper breakdown → | 2006 | 1001 |
| 4 | 2005 | 485 | |
| 5 | 2008 | 409 | |
| 6 | Complete regression of well-established tumors using a novel water-soluble poly(L-glutamic acid)-paclitaxel conjugate. | 1998 | 272 |
| 7 | 2008 | 258 | |
| 8 | 2009 | 246 | |
| 9 | Cardiac glycosides stimulate Ca2+ increases and apoptosis in androgen-independent, metastatic human prostate adenocarcinoma cells. | 2000 | 245 |
| 10 | 2008 | 237 | |
| 11 | 2006 | 203 | |
| 12 | 2001 | 195 | |
| 13 | 2005 | 184 | |
| 14 | 15-Lipoxygenase-1 mediates nonsteroidal anti-inflammatory drug-induced apoptosis independently of cyclooxygenase-2 in colon cancer cells. | 2000 | 162 |
| 15 | 2007 | 161 | |
| 16 | Oleandrin suppresses activation of nuclear transcription factor-kappaB, activator protein-1, and c-Jun NH2-terminal kinase. | 2000 | 157 |
| 17 | 1982 | 143 | |
| 18 | 1996 | 142 | |
| 19 | 2004 | 135 | |
| 20 | The human lipid phosphate phosphatase-3 decreases the growth, survival, and tumorigenesis of ovarian cancer cells: validation of the lysophosphatidic acid signaling cascade as a target for therapy in ovarian cancer. | 2003 | 124 |
About Robert A. Newman
Robert A. Newman is a scholar working on Molecular Biology, Oncology, Pharmacology, Cancer Research and Organic Chemistry, having authored 302 papers that have together received 18.3k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (42 papers), Cancer therapeutics and mechanisms (27 papers), Cancer Treatment and Pharmacology (23 papers), Estrogen and related hormone effects (18 papers), Chemotherapy-induced organ toxicity mitigation (18 papers), Eicosanoids and Hypertension Pharmacology (18 papers), Cancer, Lipids, and Metabolism (12 papers) and Retinoids in leukemia and cellular processes (12 papers). The work is most often cited by research in Molecular Medicine (4.3k citations), Biochemistry (956 citations), Pharmacology (2.6k citations), Pharmaceutical Science (836 citations) and Toxicology (467 citations). Robert A. Newman has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Bharat B. Aggarwal, Ajaikumar B. Kunnumakkara, Preetha Anand, Ephraim Philip Lansky, Peiying Yang, Keith I. Block, Alison D. Pawlus, Razelle Kurzrock, Timothy Madden and James L. Abbruzzese. Their work appears in journals such as Cancer Chemotherapy and Pharmacology, Journal of Clinical Oncology, Investigational New Drugs, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.